Author: Optogenerapy News

Optogenerapy > Articles posted by Optogenerapy News (Page 2)

Optogenerapy partner GeneXplain has built a mathematical model to further improve and optimize the optogenetic pathway of Optogenerapy’s medical device. The model, which allows to predict the behaviour of the cells involved in the production of IFN- β drug for patients suffering from multiple sclerosis, can simulate different scenarios, helping to explore the system without spending resources on experiments.   In this interview, Kamilya Altynbekova, software developer...

Read More

Researchers from the Erasmus School of Health Policy & Management of the Erasmus University Rotterdam have done a systematic literature review using scientific databases to retrieve publications on the needs and preferences of relapsing-remitting multiple sclerosis patients when making treatment decisions. The publications analysed shed light on the patients’ needs and preferences regarding treatment decisions.   The literature review suggests that for multiple sclerosis patients the most important treatment characteristics...

Read More

In Optogenerapy project, light fuels the medical device, the energy to activate the engineered cells in the chamber for the production of IFN-ß protein, a therapeutic drug proven effective for the treatment of patients with Multiple Sclerosis.   In charge of the implant’s optical design, ASE Optics explains in this interview the importance of optics for channelling the light homogenously to all the cells in the membrane,...

Read More
Optogenerapy Eurecat OA-E Meeting

Optogenerapy project has been presented during the Organic and Printed Electronics Association (OE-A) 44th Working Group Meeting, which has taken place in Aix-en-Provence, France, on October 23-24.   Moha Mashayekhi, researcher at Eurecat, has given a presentation on Optogenerapy‘s optoelectronics module during the networking coffee on publicly funded projects. In addition, the poster “Bio-electronic Cell Based Implant for Multiple Sclerosis Protein Therapy” has been exhibited.   Optogenerapy medical device consists...

Read More
Optogenerapy sterilization methods Lodz University of Technology

Optogenerapy partner Lodz University of Technology has attended at the Annual Conference of Biomaterials in Medicine and Veterinary Medicine, which has taken place in Rytro, Poland, on 2018 October 11-14. During the Conference, members of the Institute of Applied Radiation Chemistry from theLodz University of Technology have presented the poster “Potential Sterilization Methods for Implantable Device for Therapeutic Delivery”,  a thorough review of potential methods...

Read More
Optogenerapy ISBPPB

The results of a review of sterilization methods to determine which ones are most suitable for Optogenerapy’s bio-electronic implant, have been presented during the 4thInternational Society for Biomedical Polymers and Polymeric Biomaterials (ISBPPB) by Radoslaw A. Wach, researcher at the Lodz University of Technology. The Conference, which has taken place in Krakow during 15-18 July 2018, is an important meeting point for researchers working with...

Read More
NEOS design thinking session optogenerapy

By Mireia Dilmé - Exploitation, Innovation and Strategy Consultant at Eurecat   Optogenerapy partner NEOS Surgery benefitted from the innovation management task of the project with the organization of a Design Thinking session to brainstorm around the design of a new surgical instrument for Optogenerapy’s device subcutaneous implantation. The design thinking and SCAMPER methodology were applied during the session, which resulted in two concepts selected. Prototypes are...

Read More

By Mireia Dilmé - Exploitation, Innovation and Strategy Consultant at Eurecat   In today's ever-changing market environment, managing innovation effectively has become a key determinant of competitiveness and growth, allowing organisations to cross new performance thresholds. Three conditions are the baseline of innovation: it challenges orthodoxy, it is systemic and it advances over time.   Whilst most enterprises are aware of the importance of establishing formal procedures and methods...

Read More
Optogenerapy Journal Genetics Medicina

Optogenerapy partners published the paper “From Photobiolumination to Optogenerapy, Recent Advances in NIR Light Photomedicine Applications” at the Journal of Molecular and Medicine. The paper, signed by Vanessa Pierroz and Marc Folcher, scientists and lectures from the Department of Biosystems Science and Engineering at ETH Zurich, reviews the use of near-infrared (NIR) light in medical applications and explain how Optogenerapy profits from this kind of...

Read More

Whenever we think of electronics, a PCB (Printed Circuit Board) full of conductive tracks and pads of laminated copper comes to our mind. The possibilities of electronics have been multiplied with printed electronics, a new technology that allows building electronics circuits using conventional printing techniques in a diverse set of materials, and provides extra functionalities to the surfaces and allows thinner, lighter and more adaptable...

Read More
Optogenerapy